May 3, 2018 / 1:24 PM / 3 months ago

BRIEF-Coherus BioSciences Re-Submits Biologics License Application For CHS-1701

May 3 (Reuters) - Coherus BioSciences Inc:

* COHERUS BIOSCIENCES RE-SUBMITS BIOLOGICS LICENSE APPLICATION FOR CHS-1701 (PEGFILGRASTIM BIOSIMILAR CANDIDATE)

* COHERUS BIOSCIENCES - RE-SUBMISSION OF BLA FOR CHS-1701, A PEGFILGRASTIM (NEULASTA®) BIOSIMILAR CANDIDATE, TO U.S. FDA UNDER 351(K) PATHWAY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below